医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
a-三氯甲基-2-嘧啶乙醇 | 1,1,1-trichloro-3-pyrimidin-2-yl-propan-2-ol | 408533-65-3 | C7H7Cl3N2O |
|
[[5-(3-氟苯基)-2-吡啶基]甲基]膦酸二乙酯 | diethyl [5-(3-fluorophenyl)pyridin-2-yl]methylphosphonate | 380894-77-9 | C16H19FNO3P |
|
[[4-(2-吡啶基)苯基]亚甲基]-肼羧酸叔丁酯 | N1-(tert-butyloxycarbonyl)-N2-[4-(pyridine-2yl)benzylidene]hydrazone | 198904-84-6 | C17H19N3O2 |
|
[[2-(6-氨基-9H-嘌呤-9-基)乙氧基]甲基]膦酸二乙酯 | 9-[2-(diethylphosphonomethoxy)ethyl]adenine | 116384-53-3 | C12H20N5O4P |
|
[SP-4-2-(1R-反式)]-(1,2-环己烷二胺-N,N')二氯化物铂(II) | (1R,2R)-1,2-diaminocyclohexanedichloroplatinum(II) | 61848-66-6 | C6H14Cl2N2Pt |
|
[6-氯-2-(三氟甲氧基)吡啶-3-基]-三甲基硅烷 | 6-chloro-2-(trifluoromethoxy)-3-(trimethylsilyl)pyridine | 1221172-02-6 | C9H11ClF3NOSi |
|
[6-(1H-吡唑-1-基)吡啶-3-基]甲基胺 | (6-(1H-pyrazol-1-yl)pyridin-3-yl)methanamine | 956191-88-1 | C9H10N4 |
|
[5-环丙基-3-(2,6-二氯苯基)-4-异噁唑基]甲醇 | (5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methanol | 946426-89-7 | C13H11Cl2NO2 |
|
[5-溴-3-[(1R)-(2,6-二氯-3-氟苯基)乙氧基]吡啶-2-基]胺 | (R)-5-bromo-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine | 877399-00-3 | C13H10BrCl2FN2O |
|
[5-(2-呋喃基)-1H-吡唑-3-基]甲醇 | 3(5)-hydroxymethyl-5(3)-(2-furyl)pyrazole | 84978-67-6 | C8H8N2O2 |
|
[4-(羟基甲基)哌嗪-1-基]甲醇 | N,N'-piperazinediethanol | 3312-58-1 | C6H14N2O2 |
|
[4-(四氢吡喃-2-基)氧基]苯硼酸 | 4-(tetrahydro-2H-pyran-2-yloxy)phenylboronic acid | 182281-01-2 | C11H15BO4 |
|
[4-(5-噁唑基)苯基]甲醇 | [4-(1,3-oxazol-5-yl)phenyl]methanol | 179057-18-2 | C10H9NO2 |
|
[4-(4-氟苯基)-6-异丙基-2-(N-甲基-N-甲磺酰胺基)-5-嘧啶基]三苯基溴化膦 | [[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]methyl]triphenylphosphonium bromide | 885477-83-8 | Br*C34H34FN3O2PS |
|
[4-(3-甲氧基丙氧基)-3-甲基-2-吡啶基]甲醇盐酸盐 | [4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methanol hydrochloride | 675198-19-3 | C11H17NO3*ClH |
|
[4-(3,5-二氯苯基)苯基]甲胺盐酸盐 | [4-(3,5-Dichlorophenyl)Phenyl]Methylamine Hydrochloride | 518357-39-6 | C13H12Cl3N |
|
[4-(1H-吡唑-4-基)-7H-吡咯并[2,3-D]嘧啶-7-基]甲基特戊酸酯 | (4-(1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate | 1146629-77-7 | C15H17N5O2 |
|
[4,4-联吡啶]-3-胺 | 3-amino-4,4′-bipyridine | 52311-43-0 | C10H9N3 |
|
[3-(吡啶-4-基)苯基]硼酸频那醇酯 | 4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine | 1009033-83-3 | C17H20BNO2 |
|
[3-(十二烷氧基)-2-羟基丙基]二(2-羟基乙基)甲基氯化铵 | (3-(Dodecyloxy)-2-hydroxypropyl)bis(2-hydroxyethyl)methylammonium chloride | 6200-40-4 | C20H44ClNO4 |
|
[3-(二甲基氨基)丙基]三苯基磷溴化物氢溴酸盐 | [3-(dimethylamino)propyl]triphenylphosphonium bromide hydrobromide | 27710-82-3 | BrH*Br*C23H27NP |
|
[3-(三氟甲基)吡啶]甲烷磺酰氯 | (3-trifluoromethyl-phenyl)methanesulfonyl chloride | 127162-96-3 | C8H6ClF3O2S |
|
[3-(2-嘧啶基氧基)苯基]甲醇 | (3-Pyrimidin-2-yloxyphenyl)methanol | 82440-25-3 | C11H10N2O2 |
|
[3-(1-氯-3'-甲氧基螺[金刚烷-4,4'-二氧杂环丁烷]-3'-基)苯基]磷酸二氢酯 | Cspd | 142456-88-0 | C18H22ClO7P |
|
[2S-[2alpha,5alpha,6beta(S*)]]-6-(2-氨基-2-苯基乙酰氨基)-3,3-二甲基-7-氧代-4-硫杂-1-氮杂双环[3.2.0]庚烷-2-羧酸(特戊酰氧基)甲基酯单盐酸盐 | pivampicillin | 26309-95-5 | C22H29N3O6S*ClH |
|
[2S-(2alpha,5alpha,6beta)]-3,3-二甲基-7-氧代-6-(苯氧基乙酰氨基)-4-硫杂-1-氮杂双环[3.2.0]庚烷-2-羧酸 4-氧化物 | Phenoxy-methylpenicillin-sulfoxid | 4888-90-8 | C16H18N2O6S |
|
[2-甲基-3-(3-硫基丙酰氧基)-2-(3-硫基丙酰氧基甲基)丙基]3-巯基丙酸酯 | Propanoic acid, 3-mercapto-, 2-[(3-mercapto-1-oxopropoxy)methyl]-2-methyl-1,3-propanediyl ester | 10312-58-0 | C14H24O6S3 |
|
[2-氨基-2-(羟基亚氨基)-1,1-二甲基乙基]氨基甲酸苄酯 | benzyl 2-amino-2-(hydroxyimino)-1,1-dimethylethylcarbamate | 518047-98-8 | C12H17N3O3 |
|
[2-[[[1-甲基-5-[(三苯甲基)氨基]-1H-吡唑-4-基]氨基甲酰基]氨基]乙基]氨基甲酸叔丁酯 | tert-butyl (2-(3-(1-methyl-5-(tritylamino)-1H-pyrazol-4-yl)ureido)ethyl)carbamate | 689293-69-4 | C31H36N6O3 |
|
[2-(叔丁氧羰基氨基)嘧啶-5-基]硼酸 | (2-((tert-butoxycarbonyl)amino)pyrimidin-5-yl)boronic acid | 883231-25-2 | C9H14BN3O4 |
|
[2-(4-溴苯基)噻唑-4-基]甲醇 | 2-(4-bromophenyl)-4-hydroxymethylthiazole | 21160-53-2 | C10H8BrNOS |
|
[2-(4-氯苯基)-1,3-噻唑-4-基]甲醇 | (2-(4-chlorophenyl)thiazol-4-yl)methanol | 36093-99-9 | C10H8ClNOS |
|
[2-(2-羟基乙氧基)-乙基]-氨基甲酸苄基酯 | benzyl (2-(2-hydroxyethoxy)ethyl)carbamate | 145881-74-9 | C12H17NO4 |
|
[2,2’]-双噻吩-5,5‘-二甲醛 | [2,2']bithiophenyl-5,5'-dicarbaldehyde | 32364-72-0 | C10H6O2S2 |
|
[2,2-联吡啶]-6-甲醛 | 6-formyl-2,2'-bipyridine | 134296-07-4 | C11H8N2O |
|
[2,2':6',2''-三联吡啶]-4,4',4''-三甲酸 | 4,4',4''-tricarboxy-2,2':6',2''-terpyridine | 216018-58-5 | C18H11N3O6 |
|
[2,2':6',2''-三联吡啶]-4'-羧酸乙酯 | ethyl [2,2':6',2''-terpyridine]-4'-carboxylate | 148332-31-4 | C18H15N3O2 |
|
[2,2'-联吡啶]-6-羧酸 | 2,2′-bipyridine-6-monocarboxylic acid | 4392-87-4 | C11H8N2O2 |
|
[2,2'-联吡啶]-4,4'-二羧酸.6,6'-二甲基 | 6,6'-dimethyl-2,2'-bipyridine-4,4'-dicarboxylic acid | 144342-49-4 | C14H12N2O4 |
|
[1R-(1alpha,2beta,5alpha)]-1-(异丙基)-2-甲氧基-4-甲基环己烷 | menthyl methyl ether | 1565-76-0 | C11H22O |
|
[1-甲基-2-(4’-丁酸乙酯基)-5-N, N-二(2’-羟基乙基)]-1H -苯并咪唑 | ethyl 4-[5-[bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazol-2-yl]butanoate | 3543-74-6 | C18H27N3O4 |
|
[1-(6-氯吡嗪-3-基)哌啶-4-基]甲醇 | (1-(6-chloropyridazin-3-yl)piperidin-4-yl)methanol | 1094223-48-9 | C10H14ClN3O |
|
[1,2,5]恶二唑并[3,4-b]吡嗪-5,6(1H,3H)-二酮 | 5,6-dihydroxyfurazano[3,4-b]pyrazine | 24294-89-1 | C4H2N4O3 |
|
[1,2,4]噻唑并[1,5-a]吡啶-8-胺 | 8-Amino-1,2,4-triazolo<2,3-a>pyridine | 31052-95-6 | C6H6N4 |
|
[1,2,4]噻唑[4,3-a]吡嗪 | s-Triazolo<4,3-a>pyrazin | 274-82-8 | C5H4N4 |
|
[1,2,4]三氮唑[1,5-A]吡啶-6-甲醛 | [1,2,4]triazolo[1,5-a]pyridine-6-carbaldehyde | 614750-81-1 | C7H5N3O |
|
[1,2,4]三唑并[4,3-a]吡啶-5-羧酸 | [1,2,4]Triazolo[4,3-A]pyridine-5-carboxylic acid | 1234615-95-2 | C7H5N3O2 |
|
[1,2,4]三唑并[4,3-A]吡啶-7-羧酸 | [1,2,4]triazolo[4,3-a]pyridine-7-carboxylic acid | 1234616-66-0 | C7H5N3O2 |
|
[1,2,4]三唑并[1,5-a]吡啶 | s-triazolo(1,5-a)pyridine | 274-85-1 | C6H5N3 |
|
[1,2,4]三唑并[1,5-A]嘧啶-2-羧酸甲酯 | Methyl [1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylate | 1082977-64-7 | C7H6N4O2 |
|